NEW YORK, June 7-Researchers at the University of California at San Francisco will use Molecular Mining systems to analyze gene expression data during the treatment of multiple sclerosis with interferon β, the company said on June 5.
UCSF researchers are working with colleagues at the Hospital Vall d'Hebron in Barcelona to understand gene expression in healthy and diseased patients during immunotherapy.
They will use Molecular Mining informatics tools to model and predict the genetic regulatory networks that underlie the physiology of interferon treatment.
The initial phase of this collaboration is scheduled to be complete in two years.
For more information, see the company press release.